A Hydrophobic Stretch of 12 Amino Acid Residues in the Middle of α-Synuclein Is Essential for Filament Assembly

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961

α-Synuclein in Lewy bodies

Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382

α-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., & Goedert, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6469 · Cited by 2,868

Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.

(1998) · Europe PMC (PubMed Central) · Cited by 1,594

Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease

Conway, K. A., Harper, J. D., & Lansbury, P. T. (1998) · Nature Medicine · doi:10.1038/3311 · Cited by 1,520

Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease.

Uéda, K., Fukushima, H., Masliah, E., Xia, Y., Iwai, A., Yoshimoto, M., Otero, D. A., Kondo, J. D. M., Ihara, Y., & Saitoh, T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11282 · Cited by 1,469

The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system

Iwai, A., Masliah, E., Yoshimoto, M., Ge, N., Flanagan, L., Rohan de Silva, H. A., Kittel, A., & Saitoh, T. (1995) · Neuron · doi:10.1016/0896-6273(95)90302-x · Cited by 1,316

Identification of two distinct synucleins from human brain

Jakes, R., Spillantini, M. G., & Goedert, M. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00395-5 · Cited by 1,080

Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies

Spillantini, M. G., Crowther, R. A., Jakes, R., Cairns, N. J., Lantos, P. L., & Goedert, M. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00504-7 · Cited by 1,052

Characterization of a novel protein regulated during the critical period for song learning in the zebra finch

George, J. M., Jin, H., Woods, W. S., & Clayton, D. F. (1995) · Neuron · doi:10.1016/0896-6273(95)90040-3 · Cited by 844

Structural and mechanistic insights into modulation of α-Synuclein fibril formation by aloin and emodin

Meena, V. K., Kumar, V., Karalia, S., Dangi, R. S., & Sundd, M. (2022) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2022.130151 · Cited by 6

Disease mechanisms as subtypes: Lysosomal dysfunction in the endolysosomal Parkinson's disease subtype

Mamais, A., Wallings, R. L., & Rocha, E. M. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-85555-6.00009-6 · Cited by 6

Computational Study on Oligomer Formation of Fibril-forming Peptide of α-Synuclein

Park, S.-B., Yoon, J., Jang, S., Lee, K.-H., & Shin, S. (2012) · Bulletin of the Korean Chemical Society · doi:10.5012/bkcs.2012.33.3.848 · Cited by 6

Dynein‐Dependent Endo‐Lysosomal Degradation Drives Lewy Body Disorders Accompanied by Aβ Pathology

Zhou, L., Wang, Y., Liu, Y., Zhu, F., Gao, G., Li, C., Ai, P., Xu, J., Wang, J. J., Guo, L. Z., et al. (2025) · Advanced Science · doi:10.1002/advs.202414860 · Cited by 5

Mapping the Role of Monomer Conformation in the Amyloid Formation of α-Synuclein Splice Variants

Dewison, K. M., Taylor, A. I. P., Brockwell, D. J., & Radford, S. E. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c12366 · Cited by 6

Probing the Energy Landscape of α‐Synuclein Amyloid Fibril Formation by Systematic K‐to‐Q Mutagenesis

Kunka, A., Farzadfard, A., Larsen, J. A., Norrild, R. K., Saraceno, F., Fricke, C., Mohammad‐Beigi, H., Sadek, A., Folke, J., Aznar, S., et al. (2026) · Advanced Science · doi:10.1002/advs.77643 · Cited by 5

Liquid–liquid phase separation technologies of α-synuclein governed by its C-terminus via electrostatic interactions: unveiling potential therapeutic targets for Parkinson’s disease

Cui, Z., Wang, X., Zhang, Q., Li, L., & Liu, F. (2025) · Advanced technology in neuroscience . · doi:10.4103/atn.atn-d-24-00027 · Cited by 5

Key Connectomes and Synaptic‐Compartment‐Specific Risk Genes Drive Pathological α‐Synuclein Spreading

Li, Y., Torok, J., Zhang, S., Ding, J. L., Wang, N., Lau, C., Kulkarni, S., Anand, C., Tran, J., Cheng, M., et al. (2025) · Advanced Science · doi:10.1002/advs.202413052 · Cited by 5

Hydrophobic residues in the α‐synuclein NAC domain drive seed‐competent fibril formation and are targeted by peptide inhibitors

Das, V., Mousavi, S. M. M., Annadurai, N., Sukur, S., Mehrnejad, F., Moradi, S., Malina, L., Kolaříková, M., Ranc, V., Frydrych, I., et al. (2025) · FEBS Journal · doi:10.1111/febs.70222 · Cited by 5

The Interaction of Curcumin and Rosmarinic Acid with Non‐Amyloid‐Component Domain of Alpha‐Synuclein: A Molecular Dynamics Study

Kamelabad, M. R., Sardroodi, J. J., & Ebrahimzadeh, A. R. (2020) · ChemistrySelect · doi:10.1002/slct.201904799 · Cited by 5

The antiviral drug Ribavirin effectively modulates the amyloid transformation of α-Synuclein protein

Singh, P., Akhtar, A., Admane, N., & Grover, A. (2024) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2024.108155 · Cited by 5

The humoral immune landscape in Parkinson's disease: Unraveling antibody and B cell changes

Baridjavadi, Z., Mahmoudi, M., Abdollahi, N., Ebadpour, N., Mollazadeh, S., Haghmorad, D., & Esmaeili, S. (2024) · Cell Biochemistry and Function · doi:10.1002/cbf.4109 · Cited by 5

Steuerung der α‐Synuclein‐Aggregation durch Bindung einer β‐Haarnadel

Mirecka, E. A., Shaykhalishahi, H., Gauhar, A., Akgül, Ş., Lecher, J., Willbold, D., Stoldt, M., & Hoyer, W. (2014) · Angewandte Chemie · doi:10.1002/ange.201309001 · Cited by 5

A novel strategy for the targeted analysis of protein and peptide metabolites

Williamson, N. A., Reilly, C. B., Tan, C., Ramarathinam, S. H., Jones, A., Hunter, C. L., Rooney, F., & Purcell, A. W. (2009) · PROTEOMICS · doi:10.1002/pmic.201000474 · Cited by 5

Pathological and clinical aspects of alpha/beta synuclein in Parkinson’s disease and related disorders

Tolmasov, M., Djaldetti, R., Lev, N., & Gilgun‐Sherki, Y. (2016) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2016.1164600 · Cited by 5

Structural Influence and Interactive Binding Behavior of Dopamine and Norepinephrine on the Greek-Key-Like Core of α-Synuclein Protofibril Revealed by Molecular Dynamics Simulations

Zou, Y. F., Liu, Z., Zhu, Z., & Qian, Z. (2019) · Processes · doi:10.3390/pr7110850 · Cited by 5

Studies on alpha-synuclein and islet amyloid polypeptide interaction

Wang, Y., Bergström, J. J. E., Ingelsson, M., & Westermark, G. T. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1080112 · Cited by 5

The influence of zwitterionic and anionic phospholipids on protein aggregation

Ali, A., Dou, T., Holman, A. P., Hung, A., Osborne, L., Pickett, D. N., Rodriguez, A., Zhaliazka, K., & Kurouski, D. (2024) · Biophysical Chemistry · doi:10.1016/j.bpc.2024.107174 · Cited by 5

Role of Genes and Treatments for Parkinson’s Disease

Naz, F., & Siddique, Y. H. (2020) · The Open Biology Journal · doi:10.2174/1874196702008010047 · Cited by 5

Huntingtin and Other Neurodegeneration-Associated Proteins in the Development of Intracellular Pathologies: Potential Target Search for Therapeutic Intervention

Churkina, A. S., Shakhov, A. S., Kotlobay, A. A., & Alieva, I. B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415533 · Cited by 5

An Unstructured Region is Required by GAV Homologue for the Fibrillization of Host Proteins

Ji, L., Du, H., Zhang, F., Li, H., Luo, X., Hu, J., & Hu, H. (2005) · The Protein Journal · doi:10.1007/s10930-005-6713-4 · Cited by 5

Computational Modeling in Bioprocess Development

Insaidoo, F. K., Banerjee, S., Roush, D. J., & Cramer, S. M. (2017) · Wiley eBooks · doi:10.1002/9781119031116.ch6 · Cited by 5

Small molecule inhibitors targeting alpha-synuclein aggregation: Progress and future outlook

Hajam, I. B., Ahanger, I. A., Rasool, U., & Dar, T. A. (2025) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2025.08.017 · Cited by 4

From Yeast to Therapeutics: Modeling Neurodegenerative Diseases in Saccharomyces cerevisiae

Ferreira-Júnior, J. R., Camandona, V. D. L., & de Barros, M. H. (2025) · Yeast · doi:10.1002/yea.70008 · Cited by 5

Optogenetic-induced α-synuclein accumulation reveals early synaptic dysfunction in experimental models of Parkinson’s disease

Rodríguez-Aller, R., Romero-Quineche, B., Morissette, M., Sheta, R., Paolo, T. D., Saghatelyan, A., & Oueslati, A. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-01201-x · Cited by 4

Nanostructure Fabrication Based on Engineered α-Synuclein

Kobayashi, N., Han, S.-W., Nakamura, C., & Sode, K. (2008) · Nanobiotechnology · doi:10.1007/s12030-008-9011-3 · Cited by 4

α-Synuclein Fibril, Ribbon and Fibril-91 Amyloid Polymorphs Generation for Structural Studies

Bousset, L., Alik, A., Arteni, A., Böckmann, A., Meier, B. H., & Melki, R. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2597-2_23 · Cited by 5

α‐Synuclein Drives Tau's Cytotoxic Aggregates Formation through Hydrophobic Interactions

Ojeda, A. M., Cofré, V., Melo, F., Caballero, L., Fuentealba, D., & Cornejo, A. (2023) · ChemPlusChem · doi:10.1002/cplu.202300257 · Cited by 5

In vitro inhibition of α-Synuclein aggregation and disaggregation of preformed fibers by polyphenol hybrids with 2-conjugated benzothiazole

Zhao, Y., Zhang, W., Xing, L.-Z., Xu, J. P., Shi, W., & Zhang, Y. (2024) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2024.129752 · Cited by 4

Emerging perspectives on precision therapy for Parkinson’s disease: multidimensional evidence leading to a new breakthrough in personalized medicine

Wang, Q.-L., Gu, X., Yang, L., Jiang, Y., Zhang, J., & He, J. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1417515 · Cited by 4

Charge and hydrophobicity of amyloidogenic protein/peptide templates regulate the growth and morphology of gold nanoparticles

Kadu, P., Gadhe, L. G., Navalkar, A., Patel, K., Kumar, R., Sastry, M., & Maji, S. K. (2022) · Nanoscale · doi:10.1039/d2nr01942f · Cited by 4

Interneuronal In Vivo Transfer of Synaptic Proteins

Klinkenberg, M., Helwig, M., Pinto‐Costa, R., Rollar, A., Rusconi, R., Monte, D. A. D., & Ulusoy, A. (2023) · Cells · doi:10.3390/cells12040569 · Cited by 4

IM-MS and ECD-MS/MS Provide Insight into Modulation of Amyloid Proteins Self-Assembly by Peptides and Small Molecules

Taha, H. B., Chawla, E., & Bitan, G. (2023) · Journal of the American Society for Mass Spectrometry · doi:10.1021/jasms.3c00065 · Cited by 4

4-Oxo-2-Nonenal- and Agitation-Induced Aggregates of α-Synuclein and Phosphorylated α-Synuclein with Distinct Biophysical Properties and Biomedical Applications

Wang, T., Liu, W., Zhang, Q., Jiao, J., Wang, Z., Gao, G., & Yang, H. (2024) · Cells · doi:10.3390/cells13090739 · Cited by 4

Inhibitory Role of β-Casein on the α-Synuclein Aggregation Associated with Parkinson’s Disease In Vitro

Shahraki, S., Shojaei, S., & Shojaei, S. (2017) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-017-9600-x · Cited by 4

Insights into aggregation dynamics of NACore peptides from coarse‐grained simulations

Huang, R., Tang, R., Xiang-yan, S., Wang, J., Chen, K., & Tian, W. (2022) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.26405 · Cited by 4

The CFTR-derived peptides as a model of sequence-specific protein aggregation

Bąk, D., Cutting, G. R., & Milewski, M. I. (2007) · Cellular & Molecular Biology Letters · doi:10.2478/s11658-007-0014-1 · Cited by 4

Modélisation expérimentale de l’agrégation et de la propagation de l’α-synucléine dans les synucléinopathies

Bourdenx, M., Dehay, B., & Bézard, E. (2015) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)30882-9 · Cited by 6

Animal models of neurodegenerative dementing disorders other than Alzheimer's disease

Giasson, B. I., Lee, V. M. ‐., & Trojanowski, J. Q. (2004) · Clinical Neuroscience Research · doi:10.1016/j.cnr.2004.04.008 · Cited by 4

Rab27 GTPases regulate alpha-synuclein uptake, cell-to-cell transmission, and toxicityPreprint

Underwood, R., Wang, B., Pathak, A., Volpicelli‐Daley, L. A., & Yacoubian, T. A. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.17.387449 · Cited by 4

Epitope-specific antibody fragments block aggregation of AGelD187N, an aberrant peptide in gelsolin amyloidosis

Leimu, L., Holm, P., Gąciarz, A., Haavisto, O., Prince, S., Pesonen, U., Huovinen, T., & Lamminmäki, U. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107507 · Cited by 3

Seed Amplification Assays as Powerful Tools for Detecting Peripheral Biomarkers in Prion-Like Diseases

Dellarole, I. L., Lombardo, A., Ciullini, A., Cazzaniga, F. A., Domina, R., Bacınoğlu, M. B., & Moda, F. (2025) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-97055-9_13 · Cited by 3

M14 substitutions in exanatide modulate alpha‐synuclein aggregation

Panuganti, V., Manchanda, K., Bharatam, P. V., & Roy, I. (2025) · FEBS Journal · doi:10.1111/febs.70321 · Cited by 3

N-terminal KTKEGV motif lysine residues of α-Synuclein are critical for TLR2 interaction and activation

Bisht, K. S., Kumari, M., & Maiti, T. K. (2025) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2025.110701 · Cited by 3

A Rigid Supramolecular Solution to a Flexible Problem: A Multifunctional Calix[4]arene-Based Strategy to Prevent α-Synuclein Toxicity

Dell’Accantera, D., Piccinini, G., Ciabini, C., Felli, I. C., Volpi, S., Marmiroli, N., Sansone, F., & Ruotolo, R. (2026) · ACS Central Science · doi:10.1021/acscentsci.5c02416 · Cited by 3

The emerging role and therapeutic targeting of autophagy-lysosome pathway in the pathogenesis of Parkinson’s disease

Shimizu, T., Isik, S., Kamath, N., & Yue, Z. (2026) · Translational Neurodegeneration · doi:10.1186/s40035-026-00555-3 · Cited by 3

Mechanism of Aggregation of the NACore of α-Synuclein: Stable Oligomer Formation Competes with Fibril Formation with Implications for the Etiology of Parkinson’s Disease

Jin, Y., Ganguly, P., Wessel, L., Zhu, Z., Rijs, A. M., Shea, J., Buratto, S. K., & Bowers, M. T. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.6c01293 · Cited by 3

Synaptic vesicle architecture modulates α-synuclein conformation and pathogenic transitions in Parkinson’s disease

Ranjan, P. (2026) · Bioscience Reports · doi:10.1042/bsr20260364 · Cited by 3

The role of phospholipid saturation and composition in α‐synuclein aggregation and toxicity: A dual in vitro and in vivo approach

Holman, A. P., Dou, T., Matveyenka, M., Zhaliazka, K., Patel, A., Maalouf, A., Elsaigh, R., & Kurouski, D. (2025) · Protein Science · doi:10.1002/pro.70121 · Cited by 3

Chromogranin A promotes the pathological conversion of α-synuclein at the synapse in Parkinson’s disease

Liu, Y., Kong, W., Zhu, F., Jiang, J., Cui, L., Han, J., Ai, P., Li, C., Wang, Y., Liu, Y., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116562 · Cited by 3

Therapeutic Peptide SS ‐31 Modulates Membrane Binding and Aggregation of α‐Synuclein and Restores Impaired Mitochondrial Function

Stefaniak, E., Cui, B., Sun, K., Yan, X., Teng, X., & Ying, L. (2026) · Chemical Biology & Drug Design · doi:10.1111/cbdd.70332 · Cited by 3

Protein Structure and Function in Aging and Age-Related Diseases

Mittal, A., & Rath, P. C. (2020) · Springer eBooks · doi:10.1007/978-981-32-9005-1_1 · Cited by 3

Elucidation of cytotoxicity of α-Synuclein fibrils on immune cells

Matveyenka, M., Ali, A., Mitchell, C. L., Шолух, М. В., & Kurouski, D. (2024) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2024.141061 · Cited by 3

Parishin C modulates the amyloid transformation of alpha-synuclein protein by apparently interacting with the NAC domain

Akhtar, A., Singh, P., Admane, N., & Grover, A. (2025) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2025.141076 · Cited by 3

Graphene Quantum Dots Prevent α-Synucleinopathy in Parkinson’s Disease

Yoo, J. M. (2020) · Springer theses · doi:10.1007/978-981-15-2233-8_3 · Cited by 3

Structures of tau and α-synuclein filaments from brains of patients with neurodegenerative diseases

Kametani, F., & Hasegawa, M. (2022) · Neurochemistry International · doi:10.1016/j.neuint.2022.105362 · Cited by 3

Understanding the effect of the membrane-mimetic micelles on the interplay between α-synuclein and Cu(II)/Cu(I) cations

Uceda, A. B., Ramis, R., Pauwels, K., Adrover, M., Mariño, L., Frau, J., & Vilanova, B. (2023) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2023.112344 · Cited by 3

Influence of Protonation on the Norepinephrine Inhibiting α-Synuclein 71–82 Oligomerization

Wang, G., Zhu, L., Wu, X., & Qian, Z. (2023) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.3c03270 · Cited by 3

Revealing the Regulation Effect of Surface Charge at Aromatic Interface to Dynamic Conformational Changes of α‐Synuclein at Early Aggregation Stage

Zhang, Y., Wu, L., & Jiang, X. (2024) · Chinese Journal of Chemistry · doi:10.1002/cjoc.202400155 · Cited by 3

Human and Tree Shrew Alpha-synuclein: Comparative cDNA Sequence and Protein Structure Analysis

Wu, Z., Huang, Z., Jiang, Q., Dai, J., Zhang, Y., Gao, J., Sun, X., Chen, N., Yuan, Y., Li, C., et al. (2015) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-015-1789-6 · Cited by 3

Aggregation and properties of α‒synuclein and related proteins

El‐Agnaf, O. M. A., & Irvine, G. B. (2001) · Journal of Spectroscopy · doi:10.1155/2001/939274 · Cited by 3

Dimerization of Fibril-forming Segments of α-Synuclein

Yoon, J.-S. (2009) · Bulletin of the Korean Chemical Society · doi:10.5012/bkcs.2009.30.8.1845 · Cited by 3

Prion-like transmission of α-synuclein pathology in the context of an NFL null background

Rutherford, N. J., Brooks, M., Riffe, C. J., Gorion, K.-M. M., Howard, J. K., Dhillon, J.-K. S., & Giasson, B. I. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.09.054 · Cited by 3

Segmental 13 C‐Labeling and Raman Microspectroscopy of α‐Synuclein Amyloid Formation

Flynn, J. D., Jiang, Z., & Lee, J. C. (2018) · Angewandte Chemie · doi:10.1002/ange.201809865 · Cited by 3

Interactions of α‐Synuclein with Lipids and Artificial Membranes Monitored by ESIPT Probes

Shvadchak, V. V., Falomir‐Lockhart, L. J., Yushchenko, D. A., & Jovin, T. M. (2011) · Wiley eBooks · doi:10.1002/9783527634323.ch1 · Cited by 3

Glycoconjugate journal special issue on: the glycobiology of Parkinson’s disease

Brockhausen, I., Schutzbach, J. S., Wang, J., Fishwick, B., & Brockhausen, J. (2021) · Glycoconjugate Journal · doi:10.1007/s10719-021-10024-w · Cited by 3

Transthyretin has conformation-selective proteolytic activity against α-synucleinPreprint

Sárkány, Z., Gião, T., Liz, M. A., Planas, A., Macedo‐Ribeiro, S., Cardoso, I., Arsequell, G., & Martins, P. M. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.10.552896 · Cited by 3

Optimal Preservation of PFFs in Glycerol Enhances Suitability for Modeling Parkinson's Disease

Mao, H., Kuang, Y., Huang, W., Gan, T., Dai, W. H., Guo, W., Chen, M., Su, Z., Shu, H., Wu, T., et al. (2024) · Small · doi:10.1002/smll.202401552 · Cited by 2

N-Homocysteinylation of lysine residues in α-Synuclein enhances aggregation propensity and cytotoxicity in SH-SY5Y cells

Hosseini, M. M., Abdulameer, M., Altafi, R., Morshedi, D., Es‐haghi, A., Khatami, S. H., Salmani, F., Tehrani, H. S., Ehtiati, S., Goudarzi, M., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-08186-w · Cited by 2

Adoptive NK cell transfer confers neuroprotection by attenuating neuroinflammation and alpha-synuclein pathology in a mouse model of synucleinopathy

Adebowale, A., Byun, J. H., Chung, J., Lee, H. J., Gresham, D., Lim, J., & Lee, J. (2025) · Molecular Neurodegeneration Advances · doi:10.1186/s44477-025-00006-9 · Cited by 2

Precision Interdiction of α-Synuclein Folding Pathways by Molecular Tweezers

Devi, M., & Paul, S. (2025) · Biochemistry · doi:10.1021/acs.biochem.5c00519 · Cited by 2

Cardiolipin-Based Nanoparticles Inhibit α-Synuclein Fibrilization

Stykel, M. G., Medeiros, J., Ryan, T. L., Siripala, S. V., Carmago, S., Lu, P., Bamm, V. V., Coackley, C. L., & Ryan, S. D. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00688 · Cited by 3

Distinct Role of γ-Synuclein in the Regulation of Motor Performance and Behavioral Responses in Mice

Sukhanova, I. S., Chaprov, K., Morozova, O. A., Ovchinnikov, R. K., Kukharskaya, O. A., Zalevskaya, V. N., Yusupova, N. M., Lugovskaya, A. A., Ninkina, N. N., & Kukharsky, M. S. (2026) · Biomedicines · doi:10.3390/biomedicines14010092 · Cited by 2

Differences in α-synuclein conformational states in physiologically relevant pH/Na + concentrations and ammonium acetate solutions unveiled by native mass spectrometry

Bolívar, E. G. B., Fortin, J. S., Ademoye, T. A., & McLuckey, S. A. (2026) · The Analyst · doi:10.1039/d5an01336d · Cited by 2

Les synucléinopathies sont-elles des maladies à prions ?

Arotçarena, M.-L., & Dehay, B. (2018) · Pratique Neurologique - FMC · doi:10.1016/j.praneu.2018.02.006 · Cited by 2

Structural packing of the non-amyloid component core domain in α-synuclein plays a role in the stability of the fibrils

Harpaz, K. A., Lan-Mark, S., & Miller, Y. (2024) · Biophysical Chemistry · doi:10.1016/j.bpc.2024.107239 · Cited by 2

Plasma α-synuclein domain profiles across α-synucleinopathies

Pons, M., Mohaupt, P., Vialaret, J., Mondésert, E., Vignon, M., Coppens, S., Stéphane, M., Lehmann, S., & Hirtz, C. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf189 · Cited by 2

Synthetic NAC 71-82 Peptides Designed to Produce Fibrils with Different Protofilament Interface Contacts

Näsström, T., Dahlberg, T., Malyshev, D., Ådén, J., Andersson, P. O., Andersson, M. J., & Karlsson, B. C. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179334 · Cited by 2

Inhibitory mechanism of n-MTAB AuNPs for α-synuclein aggregation

Liu, R., Zhai, H. L., Zhu, M., Shao, H. P., & Wang, T. H. (2023) · Journal of Molecular Modeling · doi:10.1007/s00894-023-05513-8 · Cited by 2

Solubility of α-synuclein species in the L62 mouse model of synucleinopathy

Schwab, K., Magbagbeolu, M., Theuring, F., Harrington, C. R., Wischik, C. M., & Riedel, G. (2024) · Scientific Reports · doi:10.1038/s41598-024-56735-6 · Cited by 2

A Perspective on Interdicting in Protein Misfolding for Therapeutic Drug Design: Modulating the Formation of Nonlocal Contacts in α-Synuclein as a Strategy against Parkinson’s Disease

Bergasa-Caceres, F., & RABITZ, H. A. (2024) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.3c07519 · Cited by 2

Disordered regions of inhibitor-bound α-synuclein suppress seed-induced fibril nucleation in cells

Schulz, C. M., Agerschou, E. D., Gardon, L., Alexander, M., Stoldt, M., Heise, H., Tamgüney, G., & Hoyer, W. (2024) · Cell Reports Physical Science · doi:10.1016/j.xcrp.2024.102180 · Cited by 2

Structural Properties of Fibril-forming Segments of α-Synuclein

Yoon, J. (2009) · Bulletin of the Korean Chemical Society · doi:10.5012/bkcs.2009.30.3.623 · Cited by 2

Mitochondrial dysfunction in protein conformational disorders

Brielle, S., & Kaganovich, D. (2018) · Journal of Genetics · doi:10.1007/s12041-018-0958-0 · Cited by 2

Optical pulse labeling studies reveal exogenous seeding slows α-synuclein clearance

Croft, C. L., Paterno, G., Vause, A. R., Rowe, L. A., Ryu, D. H., Goodwin, M. S., Moran, C., Cruz, P. E., Giasson, B. I., & Golde, T. E. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00434-4 · Cited by 3

In situ single-molecule investigations of the impacts of biochemical perturbations on conformational intermediates of monomeric α-synuclein

Huang, W., Liu, J., Le, S., Yao, M., Shi, Y., & Yan, J. (2024) · APL Bioengineering · doi:10.1063/5.0188714 · Cited by 2

β-synuclein protein from Xenopus laevis: Overexpression in Escherichia coli of the GST-tagged protein and production of polyclonal antibodies

Yuan, Z., Zhao, X., Yan, F., Zhao, J., Liu, H., Xiong, S., Li, J., Chen, L., & Wei, Y. (2007) · Biochemistry (Moscow) · doi:10.1134/s0006297907110144 · Cited by 2

Getting in charge of β-synuclein fibrillation

Landau, M. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.h117.780528 · Cited by 2

Alpha-synuclein and neuroinflammation in Parkinson's disease

Varanita, T., & Bubacco, L. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815950-7.00027-8 · Cited by 2

Aplicaciones de los nanoanticuerpos en la medicina

Monge, M. C. O., Arce-Rodríguez, N., Muñoz, M. S., Rojas, M. C., Salas, M. F. R., Viales, E. B., & Redondo, G. M. (2022) · Ars Pharmaceutica (Internet) · doi:10.30827/ars.v63i2.22199 · Cited by 2

The Key Features of Catechols and α,β Unsaturated Carbonyl Moieties: Interaction With α‐syn Hydrophobic peptide and Activation of Catecholamines Pathway in Cells

Monroy-Moya, S., Caballero, J., González-Norambuena, F., Simirgiotis, M. J., Sánchez, E., Areche, C., Fuentealba, D., & Cornejo, A. (2023) · ChemistrySelect · doi:10.1002/slct.202301106 · Cited by 2

Effects and Analysis of Transglutamination on Protein Aggregation and Clearance in Neurodegenerative Diseases

Nemes, Z. (2011) · Advances in enzymology and related areas of molecular biology/Advances in enzymology and related subjects · doi:10.1002/9781118105771.ch8 · Cited by 2

Local structural dynamics of alpha-synuclein correlate with aggregation in different physiological conditionsPreprint

Seetaloo, N., Zacharopoulou, M., Stephens, A. D., Schierle, G. S. K., & Phillips, J. J. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.02.11.480045 · Cited by 2

At the Intersection Between Mitochondrial Dysfunction and Lysosomal Autophagy: Role of PD-Related Neurotoxins and Gene Products

Asiago, J. M., Doyle, T. B., Mishra, V. R., Jacquet, A. D. R., & Rochet, J. (2017) · Royal Society of Chemistry eBooks · doi:10.1039/9781782622888-00325 · Cited by 1

Neuroprotective role of Celastrus paniculatus Willd and Sida cordifolia Linn on kainic acid-induced neuronal damage in neurodegenerative diseases

Pujari, G. R., Subramanian, V., & Rao, S. R. (2022) · Pharmaceutical Sciences Asia · doi:10.29090/psa.2022.03.21.254 · Cited by 1

Conformational Dynamics of Post-Translational-Modified α-Synuclein (pY39 and pS87) and its Interaction with Lipid Membrane

Das, D., & Mattaparthi, V. S. K. (2024) · Current Biotechnology · doi:10.2174/0122115501310995240522064640 · Cited by 1

Deciphering protein aggregation: Insights into morphology, contributing factors, and molecular pathologies

Hima, S., Aiswarya, N., Remya, C., Vasudevan, D. M., Dileep, K. V., & Francis, D. (2025) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2024.11.009 · Cited by 1

The Yeast Parkinson’s Disease Model Exhibits An Increase in Peroxisome Number Independent of the Division Proteins Vps1 and Dnm1

Sarhadi, T. R., Joshi, N., & Nagotu, S. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05236-2 · Cited by 1

Comparative Analysis of Aggregation of β- and γ-Synucleins in Vertebrates

di Patti, M. C. B., Meoni, M., & Toni, M. (2025) · Biomolecules · doi:10.3390/biom15091231 · Cited by 1

Adenine bolsters the monomeric conformations of the intrinsically disordered A53T mutant of α-Synuclein protein

Singh, P., Akhtar, A., Admane, N., & Grover, A. (2025) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2025.108661 · Cited by 1

Characterization of Hydrophobic Residue Requirements for α-Synuclein Fibrillization

Waxman, E. A., Mazzulli, J. R., & Giasson, B. I. (2009) · Biochemistry · doi:10.1021/bi900539p · Cited by 110

A Peptide Motif Consisting of Glycine, Alanine, and Valine Is Required for the Fibrillization and Cytotoxicity of Human α-Synuclein

Du, H., Tang, L., Luo, X., Li, H., Hu, J., Zhou, J., & Hu, H. (2003) · Biochemistry · doi:10.1021/bi034028+ · Cited by 155

Sequence determinants regulating fibrillation of human α-synuclein

Koo, H.-J., Lee, H.-J., & Im, H. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.01.140 · Cited by 55

Sequence Determinants for Amyloid Fibrillogenesis of Human α-Synuclein

Zibaee, S., Jakes, R., Fraser, G. M., Serpell, L. C., Crowther, R. A., & Goedert, M. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.09.039 · Cited by 67

A de novo designed α-helical peptide forms amyloid fibrils which are not neurotoxic

Fezoui, Y., Hartley, D. M., Walsh, D. M., Selkoe, D. J., Osterhut, J. J., & Teplow, D. B. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)82568-3